Physician profile
Joseph Reses
NPI 1356526255
$1,178.42
in general payments reported to CMS, 2019-2025
13 companies · $108 in 2025
The $108 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2022: $141 · 2023: $744 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $327.41 | 2019-2023 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $284.54 | 2019-2023 | Xifaxan |
| Genzyme Corporation | $173.87 | 2022-2023 | |
| Janssen Biotech, INC. | $155.98 | 2023-2025 | Tremfya, Stelara |
| Ferring Pharmaceuticals INC. | $45.75 | 2022-2023 | Rebyota |
| Regeneron Healthcare Solutions, INC. | $31.80 | 2023 | Dupixent |
| Ardelyx, INC. | $29.23 | 2023 | Ibsrela |
| Pfizer INC. | $28.84 | 2023 | |
| Amgen INC. | $24.27 | 2022 | |
| Lilly USA, LLC | $21.10 | 2025 | Omvoh |
| Sandoz INC. | $19.10 | 2023 | Hyrimoz |
| Braintree Laboratories, INC. | $18.59 | 2023 | Suflave, Sutab |
| Napo Pharmaceuticals INC | $17.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Reses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.